Made-in-China New Drugs: Breaking Through the RMB 4-Billion Battlefield
In 2024, the "Billion-Yuan Club" of made-in-China first-in-class new drugs expanded to 16 members.
September 5, 2025
by lezhi
A Review of the Export Data of China’s Plant Extract Market in 2020 and Potential Varieties
In 2020, the outbreak of the pandemic stimulated consumer demand for naturally sourced plant extracts, however, China’s export value of plant extracts in the first half of 2020 reached USD1.265 billion, up only 1.08% year on year.
March 18, 2021
by PharmaSources.com
Acute myeloid leukaemia market to reach $5.1 billion by 2029: GlobalData
This growth will be driven by label expansions of the already successful drugs Venclexta, Tibsovo, Idhifa and Xospata, as well as by a strong late-stage pipeline.
June 22, 2020
by expresspharma
India: A global nutraceutical hub in the making
Scientific nutrition has always been arborvitae of India since 3300 BCE. Ayurveda is one of the most scientific ancient texts on clinical nutrition and preventive health nutrition.
June 22, 2020
by expresspharma
Cancer immunotherapy market to hit $115bn by 2023, says report
New research analysis has predicted that immunotherapy will become the oncology treatment of choice, with the market reaching $115 billion by 2023.
January 9, 2020
by europeanpharmaceuticalreview
Evolving World of Pharma: Focal Points in Pharma for 2020
This year, the global pharmaceutical market has been predicted to reach US$1.3 trillion, but what is driving this continued growth, and what factors are likely to have a major impact on the pharma industry in 2020?
January 9, 2020
by Sarah Harding
Report indicates seasonal influenza vaccine market in Asia will reach $1bn by 2028
A new report indicates that drug launches and new formulations will drive the growth of the seasonal influenza vaccine market in China, India and Japan from $914m in 2018 to $1.05bn in 2028.
January 6, 2020
by europeanpharmaceuticalreview
Global injectable drug delivery market predicted to grow 12.8 percent
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
September 26, 2019
by europeanpharmaceuticalreview
Global LC-MS market to exhibit CAGR of 6.9 percent
Research has found that the worldwide LC-MS market will be worth $2750 million by the end of the forecast period in 2024.
September 12, 2019
by europeanpharmaceuticalreview
Antibody Drug Conjugates Market to Be Worth $15bn by 2030
Antibody drug conjugates are presently recognised as a potent class of targeted anticancer therapies which will result in growth in the market.
September 2, 2019
by europeanpharmaceuticalreview
Significant number of drugs on the market not yet fully approved
A large number of drug manufacturers are failing to complete the FDA’s Accelerated Approval Program, meaning not all available drugs are fully approved, finds a study.
August 29, 2019
by europeanpharmaceuticalreview
Glenmark receives approval to market Remogliflozin and Metformin combination drug
Glenmark Pharmaceuticals recently announced that the company has received regulatory approval to market a combination of its novel, patent protected and globally-researched sodium glucose ...
August 21, 2019
by expresspharma